K. Miller
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, Breast Cancer Treatment Studies, Lung Cancer Treatments and Mutations, Prostate Cancer Treatment and Research, Cancer Treatment and Pharmacology
Most-Cited Works
- → Omission of concurrent chemoradiation after a response to neoadjuvant chemotherapy in locally advanced rectal cancer with a synchronous liver metastasis: a note of caution(2007)8 cited
- → 140 OPEN-LABEL, EXPLORATORY STUDY OF DEGARELIX AS SECOND-LINE HORMONAL THERAPY IN PATIENTS WITH PROSTATE CANCER (CS27)(2010)8 cited
- → „Zweitmeinungszentren“(2006)6 cited
- → Building a Systematic Online Living Evidence Summary of COVID-19 Research(2021)5 cited
- → Changes in alkaline phosphatase (ALP) dynamics and overall survival (OS) in metastatic castration-resistant prostate cancer (mCRPC) patients treated with radium-223 in an international early access program (EAP)(2016)4 cited
- An unusual presentation of intoeing in a child.(1998)
- → Kastrationsresistentes Prostatakarzinom 2011(2011)4 cited
- → 527 Expression of the apoptosis inhibitor survivin in testicular tissue of infertile patients(2004)3 cited
- → 192 The 10-years follow-up of the ARO 96-02/AUO AP 09/95 trial on adjuvant radiotherapy (ART) versus wait-and-see (WS) after prostatectomy for pT3 cancer – subgroup analysis(2013)3 cited
- → 7154 An International Expanded Access Program (EAP) of RAD001 (everolimus) in patients with metastatic renal cell carcinoma (mRCC) who fail, or become intolerant of a prior vascular endothelial growth factor receptor (VEGFr) therapy(2009)2 cited